Latest Breaking News On - Drug response predictor - Page 1 : vimarsana.com

Allarity Therapeutics Stenoparib Shows Clear Clinical Benefit and Achieves Significant | Region

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase

United statesThomas pedersenThomas jensenCompany contactExchange commissionCarrotize pr communicationsAllarity therapeutics incAllarity therapeuticsDrug responseRecurrent ovarianDrug response predictorPrivate securities litigation reform act

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas pedersenCompany board of directorsAllarity therapeutics incCarrotize pr communicationsCompany contactExchange commissionCompany certificate of incorporationAllarity therapeuticsReverse stock splitSpecial meetingStock splitReverse stockComputershare limitedDrug response predictorCompanion diagnosticPrivate securities litigation reform act

Allarity Therapeutics Announces 1-for-20 Reverse Stock

Boston (April 4, 2024) Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to.

Thomas pedersenAllarity therapeutics incCompany contactCompany certificate of incorporationCompany board of directorsCarrotize pr communicationsExchange commissionAllarity therapeuticsReverse stock splitSpecial meetingStock splitReverse stockComputershare limitedDrug response predictorCompanion diagnosticPrivate securities litigation reform act

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward
smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.

Thomas pedersenThomas jensenJeremyr graffAllarity thomas jensenMerck kgaaAllarity therapeutics incMerck kgaCarrotize pr communicationsCompany contactEisai coJiangsu hengrui pharmaceuticalsExchange commissionAllarity therapeuticsExecutive advisor jeremyAntibody drug conjugateComplete responder

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with

Boston (March 25, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company has

Thomas pedersenThomas jensenAllarity therapeutics incCarrotize pr communicationsCompany contactExchange commissionNasdaq hearings panel onAllarity therapeuticsNasdaq listing rulesListing ruleNasdaq hearings panelBid price ruleNasdaq capital marketCommon stockDrug response predictorPrivate securities litigation reform act